And especially if we are talking about a $1b US market annually for MSA, than add PD $6b, as the drug will be used in early diagnosis for both as they affect similar sections of the brain early and too hard to differentiate early
And especially if we are talking about a $1b US market annually...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $6.645K | 2.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 24995682 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 131374606 | 34 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |